Abstract:Shaoguang Li, 1 Zhan Lin, 1 Haobo Chen, 1 Qiu Luo, 1 Shengnan Han, 1 Kunlong Huang, 1 Ruichan Chen, 1 Yuying Zhan, 1 Bing Chen, 2 Hong Yao 1– 3 1 Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou, FuJian, People's Republic of China; 2 Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, Fujian Medical University, Fuzhou, Fujian, People's Republic of China; 3 Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, Fujian Medical University, Fuzhou, Fujian, People's Republic of China Correspondence: Shaoguang Li; Hong Yao, Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, 1 Xue Yuan Road, University Town, Fuzhou, Fujian, 350122, People's Republic of China, Email ; Background: The preclinical diagnosis of tumors is of great significance to cancer treatment. Near-infrared fluorescence imaging technology is promising for the in-situ detection of tumors with high sensitivity. Methods: Here, a fluorescent probe was synthesized on the basis of Au nanoclusters with near-infrared light emission and applied to fluorescent cancer cell labeling. Near-infrared methionine-N-Hydroxy succinimide Au nanoclusters (Met-NHs-AuNCs) were prepared successfully by one-pot synthesis using Au nanoclusters, methionine, and N-Hydroxy succinimide as frameworks, reductants, and stabilizers, respectively. The specific fluorescence imaging of tumor cells or tissues by fluorescent probe was studied on the basis of SYBYL Surflex-DOCK simulation model of LAT1 active site of overexpressed receptor on cancer cell surface. The results showed that Met-NHs-AuNCs interacted with the surface of LAT1, and C_Score scored the conformation of the probe and LAT1 as five. Results: Characterization and in vitro experiments were conducted to explore the Met-NHs-AuNCs targeted uptake of cancer cells. The prepared near-infrared fluorescent probe (Met-NHs-AuNCs) can specifically recognize the overexpression of L-type amino acid transporter 1 (LAT1) in cancer cells so that it can show red fluorescence in cancer cells. Meanwhile, normal cells (H9c2) have no fluorescence. Conclusion: The fluorescent probe demonstrates the power of targeting and imaging cancer cells. Keywords: Au nanoclusters, fluorescence imaging, cancer cell imaging, molecular docking Epidemiological studies have shown that the incidence and mortality of cancer have been increasing in recent decades. 1,2 Thus, the early screening of people who are at high risk of cancer can detect tumors in time and increase their chances of receiving treatment and cure. 3 Therefore, the use of sensitive and specific detection techniques to locate solid tumors is the first and indispensable step in the treatment of cancer patients. 4 With the continuous development of optical imaging technology for decades, it has been widely used in the preclinical diagnosis and treatment of cancer in biomedical research. 5–8 Nanomaterials for optical imaging, such as nano clusters, 9 silicon dioxide, carbon dots and magnetic materials, 10,11 have always been the focus of cancer diagnosis research because of their uniqueness. 12 The intrinsic optical properties of nanoparticles make them quickly become the best choice for various cell imaging modes. 13 Nanoparticles usually combine with suitable targeted ligands on the particle surface to form luminescent materials with different emission wavelengths because of their high sensitivity, small size, and composition. Among them, Au nanoclusters (AuNCs) have become a hot research fields of cancer cell imaging applications because of their ultra-fine size, biocompatibility (eg, bioinertia and low cytotoxicity), 14 unique and highly adjustable optical properties, and photostability. However, the most challenging issues for large-scale application of imaging Au nanoclusters of cancer cells are their specificity and sensitivity. In tumor diagnosis, distinguishing cancer cells from normal cells accurately is very important. 15,16 To improve the sensitivity and selectivity of tumor imaging, it is the most ideal method to develop targeted tumor fluorescent imaging materials that can specifically recognize the entry of overexpressed receptors into tumor cells. In recent years, a variety of functional small molecule dyes have been developed for specific targeted fluorescence imaging of specific tissues or receptors. 17–22 For example, Wang et al successfully synthesized a CP-IRT Nir-II molecular imaging probe with high affinity an -Abstract Truncated-

Tumor-Targeted Fluorescence Imaging and Mechanisms of Tumor Cell-Derived Carbon Nanodots

Ultra-Small and Metabolizable Near-Infrared Au/Gd Nanoclusters for Targeted FL/MRI Imaging and Cancer Theranostics

Intracellular Fluorescent Light-Up Bioprobes with Different Morphology for Image-Guided Photothermal Cancer Therapy

High‐Performance Red/Near‐IR Carbon Dots As Fluorescence Probes for Tumor Imaging in Vivo

Cell-Derived N/P/S-Codoped Fluorescent Carbon Nanodots with Intrinsic Targeting Ability for Tumor-Specific Phototheranostics

Tumor-Targeted Multimodal Optical Imaging with Versatile Cadmium-Free Quantum Dots.

A Tumor-targetable NIR Probe with Photoaffinity Crosslinking Characteristics for Enhanced Imaging-Guided Cancer Phototherapy

Synthesis and Application of a Near-Infrared Light-Emitting Fluorescent Probe for Specific Imaging of Cancer Cells with High Sensitivity and Selectivity

Photoluminescent Carbon Dots As Biocompatible Nanoprobes for Targeting Cancer Cells in Vitro

In vivo Imaging and Drug Storage by Quantum-Dot-Conjugated Carbon Nanotubes

Cancer Cell Membrane-Biomimetic Nanoprobes with Two-Photon Excitation and Near-Infrared Emission for Intravital Tumor Fluorescence Imaging

Recent advances of carbon dots in imaging-guided theranostics

Optical Imaging-Guided Cancer Therapy with Fluorescent Nanoparticles

Tumor Microenvironment-Responsive Gold Nanodendrites for Nanoprobe-Based Single-Cell Raman Imaging and Tumor-Targeted Chemo-Photothermal Therapy

Cancer Cell Targeting Via Selective Transferrin Receptor Labeling Using Protein-Derived Carbon Dots

Direct Solvent-Derived Polymer-Coated Nitrogen-Doped Carbon Nanodots with High Water Solubility for Targeted Fluorescence Imaging of Glioma.

Ultrasmall and Photostable Nanotheranostic Agents Based on Carbon Quantum Dots Passivated with Polyamine-Containing Organosilane Molecules.

Au:Cdhgte Quantum Dots for in Vivo Tumor-Targeted Multispectral Fluorescence Imaging

In Vivo Tumor Active Cancer Targeting and CT-fluorescence Dual-Modal Imaging with Nanoprobe Based on Gold Nanorods and InP/ZnS Quantum Dots

Tumor Microenvironment Stimuli-Responsive Fluorescence Imaging and Synergistic Cancer Therapy by Carbon-Dot-Cu2+ Nanoassemblies

In vivo cancer targeting and imaging with semiconductor quantum dots